Human Recombinant PCMT1 protein, GST Tag (V2LY-0526-LY5988)

Zhang, K., Li, J. Y., & Li, K. (2024). Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway. Chemical Biology & Drug Design, 103(6), e14559.

Zhong, J., Yuan, C., Liu, L., Du, Y., Hui, Y., Chen, Z., ... & Liu, X. (2023). PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway. Aging (Albany NY), 15(20), 11654.

Zhang, Z., Li, F., Li, Y., Li, Z., & Jia, G. (2023). In vitro anti-malignant property of PCMT1 silencing and identification of the SNHG16/miR-195/PCMT1 regulatory axis in breast cancer cells. Clinical Breast Cancer, 23(3), 302-316.

Liu, J., Liu, B., Li, Y., Mi, Z., Tan, H., & Rong, P. (2023). PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer. European Journal of Medical Research, 28(1), 289.

Guo, J., Du, X., & Li, C. (2022). PCMT1 is a potential prognostic biomarker and is correlated with immune infiltrates in breast cancer. BioMed research international, 2022(1), 4434887.

Zhang, J., Li, Y., Liu, H., Zhang, J., Wang, J., Xia, J., ... & Feng, W. (2022). Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. Journal of Experimental & Clinical Cancer Research, 41(1), 24.

Lin, Y. W., Wu, F. C., Zhuang, Y. X., Chu, L. Y., Ding, T. Y., Qu, Q. Q., ... & Hong, C. Q. (2022). PCMT1 has Potential Prognostic Value and Promotes Cell Growth and Motility in Breast Cancer.

Yuan, C., Liu, L., Du, Y., Chen, Z., Wang, L., Liu, Z., ... & Liu, X. (2022). PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.

Dong, L. M., Zhang, X. L., Mao, M. H., Li, Y. P., Zhang, X. Y., Xue, D. W., & Liu, Y. L. (2021). LINC00511/miRNA-143-3p modulates apoptosis and malignant phenotype of bladder carcinoma cells via PCMT1. Frontiers in Cell and Developmental Biology, 9, 650999.

Ozay, E. I., Shanthalingam, S., Torres, J. A., Osborne, B. A., Tew, G. N., & Minter, L. M. (2020). Protein kinase C theta modulates PCMT1 through hnRNPL to regulate FOXP3 stability in regulatory T cells. Molecular Therapy, 28(10), 2220-2236.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols